Christopher Nardo

Christopher Nardo

Corporate Officer/Principal at DERMATA THERAPEUTICS, INC.

Net worth: 441 $ as of 30/05/2024

59 year
Health Technology
Consumer Services

Profile

Dr. Christopher J.
Nardo
is a Chief Development Officer & Senior VP at Dermata Therapeutics, Inc. Dr. Nardo was previously employed as a Senior Director-Clinical Development by Allergan, Inc. and a Vice President-Clinical Operations & Biostatistics by Spectrum Pharmaceuticals, Inc. He received his undergraduate degree from Loyola Marymount University, a graduate degree from San Diego State University and a doctorate degree from The University of North Carolina at Chapel Hill.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/03/2024 115 ( 0.03% ) 441 $ 30/05/2024

Christopher Nardo active positions

CompaniesPositionStart
DERMATA THERAPEUTICS, INC. Corporate Officer/Principal 31/05/2015
All active positions of Christopher Nardo

Former positions of Christopher Nardo

CompaniesPositionEnd
ALLERGAN, INC. Corporate Officer/Principal 31/12/2014
SPECTRUM PHARMACEUTICALS, INC. Corporate Officer/Principal 31/12/2009
See the detail of Christopher Nardo's experience

Training of Christopher Nardo

The University of North Carolina at Chapel Hill Doctorate Degree
Loyola Marymount University Undergraduate Degree
San Diego State University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Nardo's experience

Connections

72

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
DERMATA THERAPEUTICS, INC.

Health Technology

SPECTRUM PHARMACEUTICALS, INC.

Health Technology

Private companies1

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Nardo